Outlook Therapeutics Inc
OTLKBuild a strategy around OTLK
Outlook Therapeutics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Cash burn of -47.0M FCF (TTM) vs 7.7M cash on hand implies ~2 months of runway without new financing. Equity is -29.0M.[Free Cash Flow]
- P/S ratio of 295.2x (TTM) vs industry median 3.1x — 95x premium on just 333K revenue, pricing in massive future sales.[P/S Ratio]
- Gross margin is -361% (TTM) — cost of revenue 4.6x total revenue. Product economics are deeply negative at current scale.[Gross Margin]
Watch Triggers
- Cash and Equivalents: Falls below 5M or new financing announced — At -47M FCF, sub-5M cash forces emergency dilution or debt, likely at punitive terms
- Total Revenue: Quarterly revenue exceeds 2M (annualized 8M+) — Would signal commercial traction inflection; current 333K TTM is negligible vs cost structure
- Gross Margin: Turns positive — At -361% TTM, positive gross margin would validate product economics and path to viability
Bull Case
98M market cap on a biotech with 21.2M R&D spend (TTM) means any commercial approval could drive multi-bagger returns from a low base. EV of 118M is modest for a late-stage pipeline.
Revenue appeared (333K TTM) — early commercial traction, however small, signals transition from pure R&D. Inventory of 3.3M and AR of 2.7M confirm product is shipping.
Bear Case
Negative equity of -29.0M, 47M annual cash burn, and only 7.7M cash creates existential financing risk. Liabilities (50.9M) are 2.3x total assets (21.9M). Dilution is near-certain.
333K revenue vs 59.4M OpEx (TTM) means the company burns $178 for every $1 earned. Gross margin of -361% shows unit economics are broken at current scale.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage OTLK's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
OTLK faces imminent dilution or debt raise within 6 months given cash burn trajectory
- FCF of -47M TTM vs 7.7M cash = ~2 months runway
- Already issued 6.9M in equity TTM; pattern likely repeats
- Total debt of 27.2M with 15.8M current portion due near-term
Revenue must scale 100x+ from 333K to justify 98M market cap — binary outcome
- 333K TTM revenue on 59.4M operating expenses
- R&D spend of 21.2M signals pre-commercial stage
- Negative equity of -29.0M limits financial flexibility
Valuation Context
Caveats
OTLK Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$190.96M | — | ||
$210.4M | — | ||
0.00 | — | ||
$333,141 | — | ||
$-1.13 | — | ||
-18,183% | -18182.8% | — | |
-18,298% | -18297.5% | — | |
$-47.05M | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
OTLK Dividend History
OTLK Stock Splits
OTLK SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/15/26 | 03/31/26 | 10-Q | |
02/17/26 | 12/31/25 | 10-Q | |
12/19/25 | 09/30/25 | Unknown | |
08/14/25 | 06/30/25 | 10-Q | |
05/15/25 | 03/31/25 | 10-Q | |
02/17/26 | 12/31/24 | 10-Q | |
02/14/25 | 12/31/24 | 10-Q | |
12/27/24 | 09/30/24 | 10-K | |
08/14/24 | 06/30/24 | 10-Q | |
05/15/24 | 03/31/24 | 10-Q | |
02/14/24 | 12/31/23 | 10-Q | |
12/22/23 | 09/30/23 | 10-K | |
08/14/23 | 06/30/23 | 10-Q | |
05/15/23 | 03/31/23 | 10-Q | |
02/14/23 | 12/31/22 | 10-Q | |
12/29/22 | 09/30/22 | 10-K | |
08/10/22 | 06/30/22 | 10-Q | |
05/13/22 | 03/31/22 | 10-Q | |
02/14/22 | 12/31/21 | 10-Q | |
12/23/21 | 09/30/21 | 10-K | |
08/13/21 | 06/30/21 | 10-Q | |
05/14/21 | 03/31/21 | 10-Q | |
02/16/21 | 12/31/20 | 10-Q | |
12/23/20 | 09/30/20 | 10-K | |
08/14/20 | 06/30/20 | 10-Q | |
05/15/20 | 03/31/20 | 10-Q | |
02/14/20 | 12/31/19 | 10-Q | |
12/19/19 | 09/30/19 | 10-K | |
08/14/19 | 06/30/19 | 10-Q | |
05/15/19 | 03/31/19 | 10-Q | |
02/14/19 | 12/31/18 | 10-Q | |
12/18/18 | 09/30/18 | 10-K | |
08/14/18 | 06/30/18 | 10-Q | |
05/15/18 | 03/31/18 | 10-Q | |
02/14/18 | 12/31/17 | 10-Q | |
12/29/17 | 09/30/17 | 10-K | |
08/14/17 | 06/30/17 | 10-Q | |
05/15/17 | 03/31/17 | 10-Q | |
02/14/17 | 12/31/16 | 10-Q | |
12/29/16 | 09/30/16 | 10-K | |
08/15/16 | 06/30/16 | 10-Q | |
06/27/16 | 03/31/16 | 10-Q | |
05/13/16 | 12/31/15 | 424B4 | |
05/13/16 | 09/30/15 | 424B4 | |
08/15/16 | 06/30/15 | 10-Q | |
06/27/16 | 03/31/15 | 10-Q | |
05/13/16 | 12/31/14 | 424B4 |